ReportWire

Tag: Focused Ultrasound

  • Some mosquitoes like it hot

    Some mosquitoes like it hot

    Newswise — Certain populations of mosquitoes are more heat tolerant and better equipped to survive heat waves than others, according to new research from Washington University in St. Louis.

    This is bad news in a world where vector-borne diseases are an increasingly global health concern. Most models that scientists use to estimate vector-borne disease risk currently assume that mosquito heat tolerances do not vary. As a result, these models may underestimate mosquitoes’ ability to spread diseases in a warming world.

    Researchers led by Katie M. Westby, a senior scientist at Tyson Research Center, Washington University’s environmental field station, conducted a new study that measured the critical thermal maximum (CTmax), an organism’s upper thermal tolerance limit, of eight populations of the globally invasive tiger mosquito, Aedes albopictus. The tiger mosquito is a known vector for many viruses including West Nile, chikungunya and dengue.

    “We found significant differences across populations for both adults and larvae, and these differences were more pronounced for adults,” Westby said. The new study is published Jan. 8 in Frontiers in Ecology and Evolution.

    Westby’s team sampled mosquitoes from eight different populations spanning four climate zones across the eastern United States, including mosquitoes from locations in New Orleans; St. Augustine, Fla.; Huntsville, Ala.; Stillwater, Okla.; St. Louis; Urbana, Ill.; College Park, Md.; and Allegheny County, Pa.

    The scientists collected eggs in the wild and raised larvae from the different geographic locations to adult stages in the lab, tending the mosquito populations separately as they continued to breed and grow. The scientists then used adults and larvae from subsequent generations of these captive-raised mosquitoes in trials to determine CTmax values, ramping up air and water temperatures at a rate of 1 degree Celsius per minute using established research protocols.

    The team then tested the relationship between climatic variables measured near each population source and the CTmax of adults and larvae. The scientists found significant differences among the mosquito populations.

    The differences did not appear to follow a simple latitudinal or temperature-dependent pattern, but there were some important trends. Mosquito populations from locations with higher precipitation had higher CTmax values. Overall, the results reveal that mean and maximum seasonal temperatures, relative humidity and annual precipitation may all be important climatic factors in determining CTmax.

    “Larvae had significantly higher thermal limits than adults, and this likely results from different selection pressures for terrestrial adults and aquatic larvae,” said Benjamin Orlinick, first author of the paper and a former undergraduate research fellow at Tyson Research Center. “It appears that adult Ae. albopictus are experiencing temperatures closer to their CTmax than larvae, possibly explaining why there are more differences among adult populations.”

    “The overall trend is for increased heat tolerance with increasing precipitation,” Westby said. “It could be that wetter climates allow mosquitoes to endure hotter temperatures due to decreases in desiccation, as humidity and temperature are known to interact and influence mosquito survival.”

    Little is known about how different vector populations, like those of this kind of mosquito, are adapted to their local climate, nor the potential for vectors to adapt to a rapidly changing climate. This study is one of the few to consider the upper limits of survivability in high temperatures — akin to heat waves — as opposed to the limits imposed by cold winters.

    “Standing genetic variation in heat tolerance is necessary for organisms to adapt to higher temperatures,” Westby said. “That’s why it was important for us to experimentally determine if this mosquito exhibits variation before we can begin to test how, or if, it will adapt to a warmer world.”

    Future research in the lab aims to determine the upper limits that mosquitoes will seek out hosts for blood meals in the field, where they spend the hottest parts of the day when temperatures get above those thresholds, and if they are already adapting to higher temperatures. “Determining this is key to understanding how climate change will impact disease transmission in the real world,” Westby said. “Mosquitoes in the wild experience fluctuating daily temperatures and humidity that we cannot fully replicate in the lab.”

    Washington University in St. Louis

    Source link

  • Artificial intelligence lowers the barrier to ultrasound brain disease treatment

    Artificial intelligence lowers the barrier to ultrasound brain disease treatment

    Newswise — Focused ultrasound technology is a non-invasive treatment method that focuses ultrasound energy on a few millimeters of the brain, including deep regions, to treat neurological disorders without opening the skull. It has been applied to the treatment of various intractable brain diseases such as depression and Alzheimer’s disease because it minimizes the impact on the surrounding healthy tissue and reduces side effects such as complications and infections. However, its use has been limited so far because it is difficult to reflect the distortion of ultrasound waves caused by the different shapes of the skulls of different patients in real-time.

    A research team led by Dr. Kim, Hyungmin of the Bionics Research Center at the Korea Institute of Science and Technology (KIST) has developed a real-time acoustic simulation technology based on generative AI to predict and correct the distortion of the ultrasound focus position caused by the skull in real-time during focused ultrasound therapy. Until now, the clinical applicability of AI simulation models in the field of non-invasive focused ultrasound therapy technology has not been validated.

    To predict the location of the invisible acoustic focus, navigation systems based on medical images taken before treatment are currently utilized, which provide information about the relative position of the patient and the ultrasound transducer. However, they are limited by their inability to account for the distortion of ultrasound waves caused by the skull, and while various simulation techniques have been used to compensate for this, they still require significant computational time, making them difficult to apply in actual clinical practice.

    The research team developed a real-time focused ultrasound simulation technology through an artificial intelligence model based on a generative adversarial neural network (GAN), a deep learning model widely used for image generation in the medical field. The technology reduces the update time of three-dimensional simulation information reflecting changes in ultrasound acoustic waves from 14 s to 0.1 s, while showing an average maximum acoustic pressure error of less than 7% and a focal position error of less than 6mm, both of which are within the error range of existing simulation technologies, increasing the possibility of clinical application.

    The research team also developed a medical image-based navigation system to verify the performance of the developed technology in order to rapidly deploy it to real-world clinical practice. The system can provide real-time acoustic simulations at the rate of 5 Hz depending on the position of the ultrasound transducer, and succeeded in predicting the position of the ultrasound energy and focus within the skull in real-time during focused ultrasound therapy.

    Previously, due to the long calculation time, the ultrasound transducer had to be precisely positioned in a pre-planned location to utilize the simulation results. However, with the newly developed simulation-guided navigation system, it is now possible to adjust the ultrasound focus based on the acoustic simulation results obtained in real-time. In the future, it is expected to improve the accuracy of focused ultrasound and provide safe treatment for patients by being able to quickly respond to unexpected situations that may occur during the treatment process.

    “As the accuracy and safety of focused ultrasound brain disease treatment has been improved through this research, more clinical applications will emerge,” said Dr. Kim, Hyungmin of KIST. “For practical use, we plan to verify the system by diversifying the ultrasound sonication environment, such as multi-array ultrasound transducers.”

    ###

    KIST was established in 1966 as the first government-funded research institute in Korea. KIST now strives to solve national and social challenges and secure growth engines through leading and innovative research. For more information, please visit KIST’s website at https://eng.kist.re.kr/

    This research was supported by the Ministry of Science and ICT (Minister Lee Jong-ho) under the Creative Convergence Research Project (CAP-18014-000) of the National Research Council of Korea. The research results were published on October 14 in the top international journal NeuroImage (top 3.6% in JCR).

    National Research Council of Science and Technology

    Source link

  • Virtual Press Briefing on Recent Advances in Focused Ultrasound

    Virtual Press Briefing on Recent Advances in Focused Ultrasound

    Focused Ultrasound Media Event

    Monday, October 24, 2022

    12–1:30 pm ET

    Reserve your spot by clicking HERE.

    Newswise — The 8th International Symposium on Focused Ultrasound – a hybrid virtual and in-person four-day event held in Bethesda, MD –, includes an interactive virtual press briefing featuring the most recent clinical and preclinical advances and emerging applications of focused ultrasound. Global experts will highlight the use of focused ultrasound – a noninvasive, therapeutic, game-changing, highly disruptive technology – in cancer immunotherapy; neuromodulation for depression; and the treatment of pancreatic cancer, pediatric brain tumors, and twin-to-twin transfusion syndrome in fetal populations. 

    The briefing will be held via Zoom with pre-recorded presentations, followed by a live Q&A.

    Featured speakers and topics include: 

    • David Attali, MD, and Marion Plaze, MD, PhD, GHU Paris Psychiatrie Neurosciences, Paris, France, will discuss the use of neuromodulation to treat psychiatric disorders.
    • Patrick Dillon, MD, Division of Hematology/Oncology, University of Virginia, will discuss the new world’s first focused ultrasound immuno-oncology center and the application of focused ultrasound in immunotherapy. 
    • Jae Young Lee, MD, Department of Radiology, Seoul National University College of Medicine, Seoul, Korea, will describe the application of ultrasound imaging in pancreatic cancer.
    • Christoph Lees, MD, and Caroline Shaw, MD, Imperial College Healthcare NHS Trust, London, United Kingdom, will speak about the use of high intensity focused ultrasound in twin-to-twin transfusion syndrome.
    • Cheng-Chia (Fred) Wu, MD, PhD, Department of Radiation Oncology, Columbia University, will discuss focused ultrasound to treat DIPG, a rare fatal brain tumor affecting children.

    The Symposium, hosted by the Focused Ultrasound Foundation, is the world’s leading forum for sharing the latest translational and clinical advances in focused ultrasound. The four-day event will spotlight breakthrough preclinical, translational, and clinical research related to one of today’s most promising and innovative therapeutic technologies. This year, we are offering members of the media FREE REGISTRATION to attend the Symposium in-person or virtually (please email Wes Myhre for the code).

    Note: You do not need a code to register for the free media event.

     

    About Focused Ultrasound

    Focused ultrasound uses ultrasound energy guided by real-time imaging to treat tissue deep in the body without incisions or radiation. It is FDA approved in the United States to treat essential tremor, tremor-dominant Parkinson’s disease, uterine fibroids, pain from bone metastases, osteoid osteoma, and the prostate. Dozens of additional indications are approved outside of the US. The technology is in various stages of research and development for more than 160 diseases, including Alzheimer’s disease and tumors of the brain, liver, breast, and pancreas.

     

    About the Focused Ultrasound Foundation

    The Focused Ultrasound Foundation was created to improve the lives of millions of people worldwide by accelerating the development of this noninvasive technology. The Foundation works to clear the path to global adoption by organizing and funding research, fostering collaboration, and building awareness among patients and professionals. Since its establishment in 2006, the Foundation has become the largest nongovernmental source of funding for focused ultrasound research. For more information, visit http://www.fusfoundation.org.

    ###

    Focused Ultrasound Foundation

    Source link